Category: Recaps

AMLI 2024 Recap for BUHLMANN Diagnostics Corp

Key Highlights BUHLMANN Diagnostics Corp proudly participated in the 37th Annual Meeting of the Association of Medical Laboratory Immunologists (AMLI) from August 16-19, 2024, in Nashville, Tennessee. This event was a significant platform for showcasing our latest advancements and contributions to medical laboratory immunology. AMLI 2024 Assays Offerings Our booth showcased a comprehensive immunology assay

BUHLMANN Diagnostics Corp’s ADLM 2024 Recap

Key Highlights We are thrilled to share the highlights of our successful participation in the Association for Diagnostics and Laboratory Medicine (ADLM) 2024 Annual Meeting & Clinical Lab Expo, held from July 28 to August 1 in Chicago, IL. ADLM 2024 Assays Offerings Our booth showcased our extensive range of fecal calprotectin (fCAL) products, the

BUHLMANN Diagnostics Corp Recap from DDW 2024

Key Highlights BUHLMANN Diagnostics Corp is excited to share highlights from our participation at Digestive Disease Week (DDW) 2024, held May 18-21 in Washington, D.C. Here is a brief overview of our assays offerings and the innovative research we presented. DDW 2024 Assays Offerings At BUHLMANN, we offer the broadest range of fecal calprotectin (fCAL)

BÜHLMANN Laboratories AG (BL), based in Basel Switzerland, has been discovering, developing & manufacturing innovative chemistry and immunological in-vitro diagnostic (IVD) and research use only (RUO) assays for almost 50 years (circa 1976). As the United States commercial affiliate of BL, BUHLMANN Diagnostics Corp (BDC), based in Amherst, NH is committed to providing exceptional sales, support, and technical services to our clinical, discovery and basic science research laboratory customers.

Category: Recaps

AMLI 2024 Recap for BUHLMANN Diagnostics Corp

BUHLMANN Diagnostics Corp’s ADLM 2024 Recap

BUHLMANN Diagnostics Corp Recap from DDW 2024

ABOUT US

SOCIAL MEDIA

QUICK LINKS

CONTACT US